Surbhi Sarna

Surbhi Sarna

Surbhi Sarna
twitter logo
linkedin logo
yc logo
Surbhi Sarna is a Group Partner at YC. She was the founder and former CEO of nVision Medical, which developed a first-in-kind microcatheter for the detection of ovarian cancer. After raising $17M in venture funding, completing three clinical trials, and obtaining two first-in-class FDA approvals, nVision was acquired by Boston Scientific (NYSE: BSX) for $275M, more than 15X money-in. Surbhi stayed at Boston Scientific for two years, running the 150+ person commercial organization in preparation for launch. She sits on both private and public company boards.

YC stats

  • Surbhi is on the board of seven companies, ranging from a Series A startup to a publicly traded company with a $12B market cap.
  • Surbhi has done more than 1,300 office hours over the course of 6 batches at YC.
  • The YC companies Surbhi has worked with are worth a combined $6 billion.
  • She's advised top YC alumni including:
YourChoice Therapeutics logoZepto logoCrossFit logoAOA Dx logo


YC Bio Fireside Series
Underrated but Unbeatable: A $275M healthcare startup success
Surbhi Sarna on nVision Medical